Please login to the form below

systemic lupus erythematosus

This page shows the latest systemic lupus erythematosus news and features for those working in and with pharma, biotech and healthcare.

BMS psoriasis drug hits the mark in phase II

BMS also has phase II studies of the drug ongoing in other indications including systemic lupus erythematosus and Crohn's disease.

Latest news

AstraZeneca’s Lupus treatment misses mark in trial

AstraZeneca’s anifrolumab has failed to meet the primary objective in a late-stage clinical trial in moderate-to-severe systemic lupus erythematosus (SLE). ... control. The result of this trial is disappointing for patients and the lupus community.”
Ablynx spurns Novo Nordisk and cuts €3.9bn deal with Sanofi

Ablynx also has vobarilizumab for systemic lupus erythematosus in phase II, with results due in the first half of the year that will trigger an option decision by AbbVie.
GSK closes in on EU approval for triple COPD therapy

Benlysta is used as an add-on treatment for adults with active, autoantibody-positive systemic lupus erythematosus (SLE).
Celgene pays $300m upfront for immunology start-up Delinia

The drug has potential in a variety of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, says Celgene, which also claims rights to related second-generation candidates.
Merck's pharma unit faces tougher 2017 as fertility boost recedes

Meanwhile, Merck suffered a setback in its mid-stage pipeline recently after its systemic lupus erythematosus (SLE) candidate atacicept failed to meet its objectives in a clinical trial, although it did

More from news
Approximately 2 fully matching, plus 27 partially matching documents found.

Latest Intelligence

Pharma deals during September 2012

In a similar vein, Biogen Idec has sold its royalty rights to Benlysta (belimunab) for the treatment of systemic lupus erythematosus, to DRI Capital Managed Fund. ... Royalty monetisation. Benlysta (belimunab) for the treatment of systemic lupus

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Santhera CEO Klaus Schollmeier joins SuppreMol

This product is SM101, which is being investigated for its use in the treatment of primary immune thrombocytopenia (ITP) and systemic lupus erythematosus (SLE).

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Random42 Scientific Communication

Creativity International Awards - Systemic Lupus Erythematosus . 2016 - Silver. Creativity International Awards - Normal Hemostasis and von Willebrand Factor (VWF). ... 2016 - Bronze. The Telly Awards - Systemic Lupus Erythematosus. 2016 - Bronze.
Random42 Scientific Communication

Creativity International Awards - Systemic Lupus Erythematosus . 2016 - Silver. Creativity International Awards - Normal Hemostasis and von Willebrand Factor (VWF). ... 2016 - Bronze. The Telly Awards - Systemic Lupus Erythematosus. 2016 - Bronze.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior Writer, Healthcare Advertising, London: Excellent package

Market Access Consultant - Greater Manchester: Negotiable

Healthcare PR Director: £100, 000 – £120, 000 benefits

Graduate Scientific Editor: DOE

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Account Manager: Negotiable

Medical Writer - Creative and Scientific Projects: DOE

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Associate Scientific Director: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Account Manager- 4 days per week or full-time: Salary TBC

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Training Manager - Surrey: Competitive Salary &Bonus

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Senior Medical Writer: Salary is DOE

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Subscribe to our email news alerts

PMHub

Add my company

AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Solaris Health looks at the gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...